Grown Rogue International Inc
CNSX:GRIN
Net Margin
Grown Rogue International Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
G
|
Grown Rogue International Inc
CNSX:GRIN
|
136.4m CAD |
-24%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
659.7B USD |
26%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
429.6B USD |
25%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
206.7B CHF |
14%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
36%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.6B GBP |
15%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
196.3B CHF |
25%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
214.8B USD |
26%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.4B USD |
-126%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
143.5B USD |
17%
|
Grown Rogue International Inc
Glance View
Grown Rogue International, Inc. operates as a seed to experience cannabis brand. The company is headquartered in Toronto, Ontario. The company went IPO on 2016-11-18. The Company’s geographical segments include the United States and Canada. The firm is a vertically integrated cannabis brand that produces and distributes cannabis products. The firm's products include sungrown and indoor flowers, along with nitro-sealed indoor, and sungrown pre-rolls and jars.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Grown Rogue International Inc's most recent financial statements, the company has Net Margin of -23.6%.
You don't have any saved screeners yet